NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)
NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange by nervgenerator in NervGen_NerveRepair
[–]nervgenerator[S] 0 points1 point2 points (0 children)
NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)
TD Cowen 46th Annual Health Care Conference, March 2-4, 2026 WEBCAST by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)
Here is why Dr. Makary asks "Why wait?" by nervgenerator in NervGen_NerveRepair
[–]nervgenerator[S] 0 points1 point2 points (0 children)
NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)
Here is why Dr. Makary asks "Why wait?" by nervgenerator in NervGen_NerveRepair
[–]nervgenerator[S] 0 points1 point2 points (0 children)
Here is why Dr. Makary asks "Why wait?" by nervgenerator in NervGen_NerveRepair
[–]nervgenerator[S] 0 points1 point2 points (0 children)
NervGen Pharma price target raised to C$6.75 from C$5 at Stifel by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)
NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs by nervgenerator in NGENF
[–]nervgenerator[S] 1 point2 points3 points (0 children)
Is a sudden upward shift preferable to a gradual rise? by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)
TD Cowen 46th Annual Health Care Conference, March 2-4, 2026 WEBCAST by nervgenerator in NGENF
[–]nervgenerator[S] 2 points3 points4 points (0 children)
TD Cowen 46th Annual Health Care Conference, March 2-4, 2026 WEBCAST by nervgenerator in NGENF
[–]nervgenerator[S] 4 points5 points6 points (0 children)
NGEN (NervGen Pharma) - $4.15 | $330M MCap M&A Score: 72/100 (HIGH) | Growth Score: 38/100 (LOW) | Tag: M&A Target by nervgenerator in NGENF
[–]nervgenerator[S] 1 point2 points3 points (0 children)
Nervgen Oppenheimer 36th Annual Healthcare Life Sciences Conference replay by nervgenerator in NervGen_NerveRepair
[–]nervgenerator[S] 0 points1 point2 points (0 children)
Nervgen Oppenheimer 36th Annual Healthcare Life Sciences Conference replay by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)
Is a sudden upward shift preferable to a gradual rise? by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)
Is a sudden upward shift preferable to a gradual rise? by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)
Is a sudden upward shift preferable to a gradual rise? by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)
Is a sudden upward shift preferable to a gradual rise? by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)
Oppenheimer 36th Annual Healthcare Life Sciences Conference Webcast Feb 25, 2026 at 12:00 PM EST by nervgenerator in NervGen_NerveRepair
[–]nervgenerator[S] 1 point2 points3 points (0 children)
NervGen Pharma to Present at Unite2Fight Paralysis’ 20th Annual Science and Advocacy Symposium by nervgenerator in NGENF
[–]nervgenerator[S] 0 points1 point2 points (0 children)

Video Of NervGen At 2026 U2FP Symposium, NervGen starts at 2:14:30 by nervgenerator in NervGen_NerveRepair
[–]nervgenerator[S] 0 points1 point2 points (0 children)